SOPHIE is brought to you by Innovation Factory

About us

Despite all modern advancements in reconstructive surgery for peripheral nerve repair, recovery remains painful, frustrating, and unsatisfactory due to the absence of treatment options. Without medications or devices to support recovery after surgery for transected or severely compressed nerves, patients are often left with long term numbness, pain and loss of movement, impacting their quality of life and earning potential. Epineuron is a clinical-stage medical device company developing the first therapeutic treatment for injured peripheral nerves. The company’s lead product delivers a unique bioelectronic therapy that accelerates nerve regeneration, resulting in better and earlier overall functional recovery (movement and sensation) for patients. It’s a single-use wearable used after nerve repair surgery and has been designated a Breakthrough Device by the FDA.

Program engagement

Leadership:

Sergio Aguirre

Founder and CEO

Mike Willand

Founder and CTO

Intellectual Property

Stage:

Sector:

Subsector: